The Personal Genome Project will now involve volunteers and researchers in China, with the hope of increasing data diversity
The idea that Alzheimer’s disease could spread via blood transfusions, has been causing a stir, and a new study has proved that this could be the truth.
Bionano Genome Mapping found to be superior to existing clinical tests for the identification of pathogenic structural variants in DMD.
AstraZeneca celebrated FDA drug approval this week, for a rare type of cancer, but elsewhere an asthma drug trial has not been as successful.
Celgene has had a tough year, once viewed as a powerhouse, now many are left contemplating whether a biotech is what they need to improve their status.
An AI-powered system built by Japanese researchers can detect bowel cancer in less than a second, and could remove the need for needless surgery.
Precision medicine is not always so precise when applied to some of the world’s most diverse populations, according to a new study.
CEO of Sarepta Therapuetics, Douglas Ingram has revealed that its FDA approved drug for Duchenne muscular dsytrophy has seen positive effects.
Ex-co-founder and CSO of Sanofi, John Hood could pull off the comeback of the decade if he manages to secure FDA approval for myelofibrosis drug.
CBSN has reported on the successes of the NIH’s BabySeq Project and some of the privacy and discrimination concerns parents have voiced about sequencing their children
A flexible Food and Drug Administration has once again rescued a biotech company seeking a drug approval based on flawed clinical trial data.